技師長承認

委員会審査

記録作成

Q31 F1 論文記録
年

印
月 日年

印
月 日年

印
月 日

和文原著
1.

迎伸孝; 森岡隆人; 濱村威; 佐山徹郎; 山本邦子; 貴戸智美; 重藤寛史; 酒田あゆみ; 鈴木諭; 石津棟瑛; 橋口公章;佐々木富男. 2010. "発作時頭皮上脳波でてんかん原性域の側方性が診断できなかった内側側頭葉てんかんの１手術例." 臨床脳波, 52（5）, 299-305.

2.

持丸朋美; 内田勇二郎; 諸熊由子; 与賀田聡子; 清祐麻紀子; 藤瀬雅子; 筒井俊治; 江藤ふじ子; 下野信行; 栢森裕三;康東天. 2010. "１大学病院で４年間に分離された imp-19 およびimp-1 型メタロ-Β-ラクタマーゼ産生 Acinetobacter baumannii の薬剤感受性と分子疫学的解析." 日本臨床微生物学雑誌, 20, 28-37.

3.

清祐麻紀子; 永沢善三; 草場耕二; 正木孝幸; 吉村尚江; 籐洋美; 光井朋子; 大坪千麻; 成田千加; 師岡津代子; 宮本比呂志;永山在明. 2010. "自動機器を用いた薬剤感受性試験の再現性 と 特 性 に 関 す る 比 較 研 究 ." Journal of the Association for Rapid Method andAutomation in Microbiology, Vol.21(1), 1-11.

和文総説
1.

内海健. 2010. "ミトコンドリア dna 維持制御因子とがん." 臨床化学, 39, 253-59.

英文原著
1.

Amano, J.; N. Masuyama; Y. Hirota; Y. Tanaka; Y. Igawa; R. Shiokawa; T. Okutani; T.
Miyayama; M. Nanami;M. Ishigai. 2010. "Antigen-Dependent Internalization Is Relatedto Rapid Elimination from Plasma of Humanized Anti-Hm1.24 Monoclonal Antibody."
Drug Metab Dispos, 38(12), 2339-46.

2.

Izumi, H.; T. Wakasugi; S. Shimajiri; A. Tanimoto; Y. Sasaguri; E. Kashiwagi; Y.
Yasuniwa; M. Akiyama; B. Han; Y. Wu; T. Uchiumi; T. Arao; K. Nishio; R. Yamazaki;K.
Kohno. 2010. "Role of Znf143 in Tumor Growth through Transcriptional Regulation ofDNA Replication and Cell-Cycle-Associated Genes." Cancer Sci, 101(12), 2538-45.

3.

Ohzono, C.; S. Etoh; M. Matsumoto; K. I. Nakayama; Y. Hirota; Y. Tanaka;H. Fujita.
2010. "Nedd4-Interacting Protein 2, a Short Half-Life Membrane Protein Degraded inLysosomes, Negatively Controls Down-Regulation of Connexin43." Biol Pharm Bull,33(6), 951-7.

4.

Shiota, M.; M. Eto; A. Yokomizo; Y. Tada; A. Takeuchi; M. Itsumi; K. Tatsugami; T.
Uchiumi;S. Naito. 2010. "Sensitivity of Doxorubicin-Resistant Cells to Sorafenib:
Possible Role for Inhibition of Eukaryotic Initiation Factor-2alpha Phosphorylation." IntJ Oncol, 37(2), 509-17.

2009 年 8 月 24 日改訂

1/3

九州大学病院検査部

Q31 F1 論文記録

5.

Shiota, M.; M. Eto; A. Yokomizo; Y. Tada; A. Takeuchi; D. Masubuchi; J. Inokuchi; K.
Tatsugami; K. Kuroiwa; T. Uchiumi; N. Seki;S. Naito. 2010. "Sorafenib with
Doxorubicin Augments Cytotoxicity to Renal Cell Cancer through Perk Inhibition." Int J
Oncol, 36(6), 1521-31.

6.

Shiota, M.; Y. Song; A. Yokomizo; Y. Tada; K. Kuroiwa; M. Eto; Y. Oda; J. Inokuchi; T.
Uchiumi; N. Fujimoto; N. Seki;S. Naito. 2010. "Human Heterochromatin Protein 1Isoform Hp1beta Enhances Androgen Receptor Activity and Is Implicated in Prostate
Cancer Growth." Endocr Relat Cancer, 17(2), 455-67.

7.

Shiota, M.; A. Yokomizo; M. Itsumi; T. Uchiumi; Y. Tada; Y. Song; E. Kashiwagi; D.
Masubuchi;S. Naito. 2010. "Twist1 and Y-Box-Binding Protein-1 Promote Malignant
Potential in Bladder Cancer Cells." BJU Int.

8.

Shiota, M.; A. Yokomizo; E. Kashiwagi; Y. Tada; J. Inokuchi; K. Tatsugami; K. Kuroiwa;
T. Uchiumi; N. Seki;S. Naito. 2010. "Foxo3a Expression and Acetylation Regulate
Cancer Cell Growth and Sensitivity to Cisplatin." Cancer Sci, 101(5), 1177-85.

9.

Shiota, M.; A. Yokomizo; D. Masubuchi; Y. Tada; J. Inokuchi; M. Eto; T. Uchiumi; N.
Fujimoto;S. Naito. 2010. "Tip60 Promotes Prostate Cancer Cell Proliferation byTranslocation of Androgen Receptor into the Nucleus." Prostate, 70(5), 540-54.

10. Shiota, M.; A. Yokomizo; Y. Tada; J. Inokuchi; E. Kashiwagi; D. Masubuchi; M. Eto; T.
Uchiumi;S. Naito. 2010. "Castration Resistance of Prostate Cancer Cells Caused byCastration-Induced

Oxidative

StressthroughTwist1andAndrogen Receptor

Overexpression." Oncogene, 29(2), 237-50.
11. Shiota, M.; A. Yokomizo; Y. Tada; J. Inokuchi; K. Tatsugami; K. Kuroiwa; T. Uchiumi; N.
Fujimoto; N. Seki;S. Naito. 2010. "Peroxisome Proliferator-Activated Receptor Gamma
Coactivator-1alpha Interacts with the Androgen Receptor (Ar) and Promotes ProstateCancer Cell Growth by Activating the Ar." Mol Endocrinol, 24(1), 114-27.
12. Shiota, M.; A. Yokomizo; Y. Tada; T. Uchiumi; J. Inokuchi; K. Tatsugami; K. Kuroiwa; K.
Yamamoto; N. Seki;S. Naito. 2010. "P300/Cbp-Associated Factor Regulates Y-Box
Binding Protein-1 Expression and Promotes Cancer Cell Growth, Cancer Invasion andDrug Resistance." Cancer Sci, 101(8), 1797-806.
13. Takazaki, S; Y Abe; T Yamaguchi; M Yagi; T Ueda; D Kang;N Hamasaki. 2010.
"Mutation of His 834 in Human Anion Exchanger 1 Affects Substrate Binding. ."Biochim Biophys Acta, 1798, 903-08.
14. Tero, A.; S. Takagi; T. Saigusa; K. Ito; D. P. Bebber; M. D. Fricker; K. Yumiki; R.
Kobayashi;T. Nakagaki. 2010. "Rules for Biologically Inspired Adaptive Network
Design." Science, 327(5964), 439-42.
15. Uchida, Y.; T. Mochimaru; Y. Morokuma; M. Kiyosuke; M. Fujise; F. Eto; Y. Eriguchi; Y.

2009 年 8 月 24 日改訂

2/3

九州大学病院検査部

Q31 F1 論文記録

Nagasaki; N. Shimono;D.

Kang. 2010.

"Clonal Spreadin

Eastern Asia of

Ciprofloxacin-Resistant Escherichia Coli Serogroup O25 Strains, and AssociatedVirulence Factors." Antimicrobial Agents, 35, 444-50.
16. Uchida, Y.; T. Mochimaru; Y. Morokuma; M. Kiyosuke; M. Fujise; F. Eto; Y. Harada; M.
Kadowaki;N.

Shimono;D.

Kang.

2010.

"GeographicDistribution

ofFluoroquinolone-Resistant Escherichia Coli Strains in Asia." Antimicrobial Agents, 35,387-91.
17. Uchiumi, T.; K. Ohgaki; M. Yagi; Y. Aoki; A. Sakai; S. Matsumoto;D. Kang. 2010. "Eral1
Is Associated with Mitochondrial Ribosome and Elimination of Eral1 Leads toMitochondrial Dysfunction and Growth Retardation." Nucleic Acids Res, 38(16),5554-68.
18. Yamaguchi, T; T Fujii; Y Abe; T Hirai; D Kang; K Namba; N Hamasaki;K Mitsuoka.
2010. "Helical Image Reconstruction of the Outward-Open Human Erythrocyte Band 3
Membrane Domain in Tubular Crystals." J Struct Biol, 169, 406-12.
19. Yamaguchi, T; Y Ikeda; Y Abe; H Kuma; D Kang; N Hamasaki;T.

Hirai. 2010.

"Structure of the Membrane Domain of Human Erythrocyte Anion Exchanger 1
Revealed by Electron Crystallography." J Mol Biol, 397, 179-89.

2009 年 8 月 24 日改訂3/3

九州大学病院検査部